In partnership with the International Women in Science (iWiS), we are very excited to announce our joint event in Basel with guest speakers Christine K. Jacob, founder & managing director of Digi-Bridges, Silja Chouquet, founder & CEO of merakoi, and Dr. Helene Mountz, Global Marketing Director, PAH Market Development, Actelion – Johnson & Johnson with the topic “Digital Healthcare: Transforming Patient Care”.
WHAT IS THIS EVENT ABOUT AND WHY IS THIS RELEVANT
Big Data is reinventing how we address global healthcare challenges. Good quality healthcare data and lots of it can power groundbreaking medical innovation. Data informs strategic healthcare policies, and can potentially, when used in collaboration with Artificial Intelligence technology, minimize global health risks through improved prediction. Factors such as rampant bad data as well as public distrust in data privacy and digital healthcare solutions, continue to present significant challenges.
Christine Jacob, founder and managing director of Digi-Bridges will present: The Promise of Health Data: Is it really the new Oil? Research shows that clinicians express concerns related to issues such as data safety and security, interpretation, analysis, and dissemination, the flexibility to adjust what to track and how records and summaries are presented, and workflow integration. So what does this really mean and what can be done about it?
Silja Chouquet, founder and CEO of merakoi will share how we can build digital trust with the online community effectively and ethically by engaging with patient experts, so they can benefit from digital health solutions. What are the key touch-points in the patient journey where digital health solutions can add the most value?
Dr. Helene Mountz, Global Marketing Director, PAH Market Development, Actelion – Johnson & Johnson will share her experience of working with a group of key stakeholders in developing and launching such a digital project, with the aim to benefit both clinicians and patients suffering from pulmonary hypertension. Engaging clinicians to learn how to detect a rare disease, for the benefit of patients is the driver of the Echoright working team, and we will see how this initiative is positioned as the first step of a global mid- to long-term digital approach to medical education and is part of a global initiative, dedicated to further accelerating the diagnosis of this rare condition in populations at risk.
6:30 – 6:40 pm: iWiS introduction, Bejal Joshi Founder and CEO iWiS
6:40 – 7:00 pm: Christine Jacob, Founder and Managing Director of Digi-Bridges
7:00 – 7:20 pm: Helene Mounty, Global Marketing Director, PAH Market Development, Actelion
7:20 – 7:40 pm: Silja Chouquet, Founder and CEO of merakoi
7:40 – 8:00 pm: Panel Q&A/Discussion moderated by Jolanda Groenhuijzen, Co-Founder iWiS
8:00 – 8:15 pm: iWiS/WiDH power of collaboration
8:15 -9:30 pm: Special apéro
Der Teufelhof Basel
Join us at the event and be inspired!